GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
₹3,295.3
INR+41.30(+1.27%)
As of June 18, 2025 9:41:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹55124.72 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹54547.47 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
59.29
Forward P/E
Price to Earnings ratio based on forecasted earnings
56.20
PEG Ratio
Price/Earnings to Growth ratio
56.20
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
14.70
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
63.88%
Operating Margin
Operating income as a percentage of revenue
33.07%
Return on Equity
Net income as a percentage of shareholders' equity
49.75%
Revenue (TTM)
Total revenue over trailing 12 months
₹3749.21 Cr+4.8%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹1323.29 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹54.88+35.199999999999996%
Balance Sheet
Total Cash
Total cash and short-term investments
₹2498.10 Cr
Total Debt
Total short-term and long-term debt
₹9.95 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
0.51%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹1921 - ₹3515.7
Beta
Measure of stock's volatility compared to the market
0.04
Shares Outstanding
Total number of shares issued by the company
₹16.94 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
446.67%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
111.67%
Payout Ratio
Percentage of earnings paid as dividends
58.44%
